4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000015
Chief Medical Officer sold 2,383 shares at an average $23.83 ($56,782)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Macias William L. Chief Medical Officer | 2025-01-15 | Sale | −1,883 | $23.81 | $44,834 | 359,908 | D |
| Macias William L. Chief Medical Officer | 2025-01-15 | Sale | −94 | $24.19 | $2,274 | 359,814 | D |
| Macias William L. Chief Medical Officer | 2025-01-15 | Sale | −387 | $23.81 | $9,214 | 359,427 | D |
| Macias William L. Chief Medical Officer | 2025-01-15 | Sale | −19 | $24.19 | $460 | 359,408 | D |
| Open-market sales · 2,383 sh · avg $23.83 · $56,782 | |||||||
Loading xslF345X05/wk-form4_1737148045.xml…